Clinical Trials Directory

Trials / Unknown

UnknownNCT03692130

Treatment of Depression With Mindfulness, Acceptance and Commitment

Mindfulness, Acceptance and Commitment Combined in Cognitive Behavioral Group Therapy (MAC-CBT®) for Patients With Depression

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Neuropsychiatrischen Zentrums Hamburg-Altona · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Randomized trial to proof the effects and efficacy of a new mindfulness and acceptance based group-treatment for depressive patients

Detailed description

In this study, a randomized trial is conducted in which the participants are allocated to two different care services (MAC-CBT® vs. progressive muscle relaxation). Participants are patients with depression who have been made aware of the group therapy by their treating physicians or psychotherapists or who have read the advertising in waiting areas or on the investigators homepage. An extensive psychometric survey will be conducted at the start of the study in an interview session with a psychotherapist, who also judges if the participants are able to participate in a therapy group. The MAC-CBT® group receives an eight-session group therapy, in which the aspects of mindfulness, acceptance and commitment are taught in detail. The control group will receive an eight-session treatment with progressive muscle relaxation. Input and output results are determined using validated survey instruments. In addition, the investigators will check the data for moderating variables (e.g. age, gender, previous treatments...).

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness, Acceptance and Commitment-TherapyPsychotherapeutic intervention to treat depressive patients with special exercises and education to be mindful, to accept situations and behaviors and to commit with the situation or the possibility to change.
BEHAVIORALJacobsonRelaxation treatment in technique of Jacobson

Timeline

Start date
2019-03-18
Primary completion
2021-12-01
Completion
2022-03-01
First posted
2018-10-02
Last updated
2021-08-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03692130. Inclusion in this directory is not an endorsement.